Intratumoral heterogeneity of intrahepatic cholangiocarcinoma

No personalized therapy regimens could demonstrate a benefit in survival of intrahepatic cholangiocarcinoma (iCCA). Since genetic heterogeneity might influence single biopsy based targeted therapy or the outcome of clinical trials, aim of the present study was to investigate intratumoral heterogenei...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Walter, Dirk, Döring, Claudia, Feldhahn, Magdalena, Battke, Florian, Hartmann, Sylvia, Winkelmann, Ria, Schneider, Markus, Bankov, Katrin, Schnitzbauer, Andreas, Zeuzem, Stefan, Hansmann, Martin Leo, Peveling-Oberhag, Jan
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2017
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5362457/
https://ncbi.nlm.nih.gov/pubmed/28146430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14844
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items